Safe Supply Streaming Co. Ltd. Provides Investor Update on its Portfolio Company "Safety Strips Tech Corp."
Safe Supply Streaming Co. announces updates on its portfolio company Safety Strips Tech Corp., which has secured an exclusive U.S. distribution agreement with Greenlane Holdings Inc. for its proprietary test strips. The products detect substances like fentanyl and xylazine, addressing the opioid crisis through affordable testing solutions. The ISO 13485 validated Fentanyl Test Strip can detect trace amounts of synthetic opioids within five minutes. The company plans to expand distribution through universities and government programs, leveraging partnerships to maximize market reach of these high-margin products.
Safe Supply Streaming Co. annuncia aggiornamenti sulla sua azienda in portafoglio Safety Strips Tech Corp., che ha ottenuto un accordo di distribuzione esclusivo negli Stati Uniti con Greenlane Holdings Inc. per le sue strisce di test proprietarie. I prodotti sono in grado di rilevare sostanze come il fentanyl e lo xilazina, affrontando la crisi degli oppioidi attraverso soluzioni di test accessibili. La striscia di test per il fentanyl, validata ISO 13485, è in grado di rilevare quantità residue di oppioidi sintetici in cinque minuti. L'azienda prevede di ampliare la distribuzione attraverso università e programmi governativi, sfruttando le partnership per massimizzare la portata di mercato di questi prodotti ad alta marginalità.
Safe Supply Streaming Co. anuncia actualizaciones sobre su empresa en cartera Safety Strips Tech Corp., que ha asegurado un acuerdo de distribución exclusivo en EE. UU. con Greenlane Holdings Inc. para sus tiras de prueba patentadas. Los productos detectan sustancias como el fentanilo y la xilazina, abordando la crisis de los opioides a través de soluciones de prueba asequibles. La tira de prueba de fentanilo, validada por ISO 13485, puede detectar cantidades traza de opioides sintéticos en cinco minutos. La empresa planea expandir su distribución a través de universidades y programas gubernamentales, aprovechando asociaciones para maximizar el alcance de mercado de estos productos de alto margen.
Safe Supply Streaming Co.는 포트폴리오 회사인 Safety Strips Tech Corp.에 대한 업데이트를 발표했습니다. 이 회사는 Greenlane Holdings Inc.와 독점적인 미국 유통 계약을 체결하여 자사 고유의 테스트 스트립을 공급하게 되었습니다. 이 제품은 펜타닐과 질라신 같은 물질을 감지하여 저렴한 테스트 솔루션을 통해 오피오이드 위기를 해결합니다. ISO 13485 인증을 받은 펜타닐 테스트 스트립은 5분 이내에 합성 오피오이드의 미량을 검출할 수 있습니다. 이 회사는 대학 및 정부 프로그램을 통해 유통을 확대할 계획이며, 파트너십을 활용하여 이 고마진 제품의 시장 도달 범위를 극대화할 예정입니다.
Safe Supply Streaming Co. annonce des mises à jour concernant sa société de portefeuille Safety Strips Tech Corp. qui a obtenu un accord de distribution exclusif aux États-Unis avec Greenlane Holdings Inc. pour ses bandes de test propriétaires. Les produits détectent des substances comme le fentanyl et la xylazine, répondant ainsi à la crise des opioïdes grâce à des solutions de test abordables. La bande de test pour le fentanyl, validée ISO 13485, peut détecter des quantités trace d'opioïdes synthétiques en cinq minutes. L'entreprise prévoit d'élargir sa distribution à travers les universités et les programmes gouvernementaux, tirant parti de partenariats pour maximiser la portée de marché de ces produits à forte marge.
Safe Supply Streaming Co. kündigt Aktualisierungen zu ihrem Portfolio-Unternehmen Safety Strips Tech Corp. an, das einen exklusiven Vertriebsvertrag in den USA mit Greenlane Holdings Inc. für seine proprietären Teststreifen gesichert hat. Die Produkte erkennen Substanzen wie Fentanyl und Xylazin und gehen somit der Opioidkrise mit erschwinglichen Testlösungen entgegen. Der nach ISO 13485 validierte Fentanyl-Teststreifen kann innerhalb von fünf Minuten Spuren synthetischer Opioide nachweisen. Das Unternehmen plant, den Vertrieb über Universitäten und Regierungsprogramme auszubauen und Partnerschaften zu nutzen, um die Marktreichweite dieser margenstarken Produkte zu maximieren.
- Secured exclusive U.S. distribution agreement with Greenlane Holdings
- Products are ISO 13485 validated
- High-margin product portfolio
- Established distribution channels and strategic partnerships
- None.
Portfolio includes Safety Strips Tech Corp.'s innovative, low-cost test strips offer an affordable and reliable way for individuals to detect dangerous substances like fentanyl and xylazine, addressing the escalating opioid crisis.
Safe Supply Streaming Co. Ltd. to leverage strategic partnerships and robust distribution networks to maximize the impact and reach of these high-demand, high-margin products.
Plans underway to explore opportunities within educational institutions and government programs, expanding the scope and impact of Safety Strips Tech Corp.
Toronto, Ontario--(Newsfile Corp. - November 11, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or the "Company") is pleased to provide an update on its portfolio company Safety Strips Tech Corp. ("Safety Strips"), which specializes in medical testing technologies and harm reduction solutions. Safety Strips has entered into a definitive agreement with Greenlane Holdings Inc. ("Greenlane") (NASDAQ: GNLN). Under the terms of this multi-year distribution agreement, Greenlane will be the exclusive U.S. distributor of Safety Strips' proprietary test strips for detecting fentanyl, xylazine and other substances used for drinking spiking.
Safety Strips' Innovative Testing Solutions
"Expanding our product distribution footprint is a key step in advancing our strategic goals, especially as the opioid crisis continues to pose a significant public health challenge," stated Geoff Benic, CEO of Safety Strips Tech Corp. "We see a clear, growing demand for dependable and economical substance testing methods that help prevent accidental overdoses and safeguard against drug-related crimes such as drug-induced assaults."
The Safety Strips' test portfolio comprises low-cost strips designed to detect the presence of fentanyl and xylazine (known as "tranq"). The Fentanyl Test Strip (FTS) is an ISO 13485 validated product and serves as an effective lateral flow immunoassay capable of detecting trace amounts of synthetic opioids, including multiple fentanyl analogs.
To conduct a test, users mix a small sample with water and immerse the test strip for 15 seconds. Results are read within approximately five minutes: one line indicates the presence of fentanyl, while two lines signify a negative result. This straightforward process helps detect ultra-low amounts of harmful substances in powders, pills, or injectables, effectively supporting harm reduction efforts.
Expanding Market Reach and Strategic Benefits
Management believes that the addition of these high-margin test strips strengthens Safe Supply's product offerings, enhances revenue potential and expands Safe Supply's capabilities in the harm reduction sector. The Company plans to leverage its partnerships, distribution channels, and strategic operations teams to promote and support the adoption of Safety Strips' products across various markets.
"Given the consistent demand for reliable, high-quality harm reduction tools, we are thrilled to announce this advancement," said Bill Panagiotakopoulos, a CEO and Director of Safe Supply. "Safety Strips Tech Corp.'s technology is unmatched in its quality and cost-efficiency, making their partnership with Greenlane a cornerstone of its product expansion strategy."
Availability and Market Rollout
Safety Strips' products are available for purchase through various distribution channels. Safe Supply intends to leverage this partnership to explore potential collaborations with universities and government programs, aiming to make these important testing tools accessible to the communities that need them most.
About Safe Supply Streaming Co. Ltd.
Safe Supply Streaming Corp. is a forward-thinking company focused on harm reduction, wellness technology, and innovative solutions that respond to critical public health needs. The Company's goal is to expand the accessibility and awareness of products that protect individuals and reduce risks associated with substance use and contamination.
For more information, please visit: https://safesupply.com/
For further information, regarding Safe Supply or the contents of this press release, please contact Bill Panagiotakopoulos, Chief Executive Officer and Director of Safe Supply, at bill@safesupply.com.
On behalf of the Board of Directors of Safe Supply Streaming Co. Ltd.
Bill Panagiotakopoulos
Chief Executive Officer and Director
Email: info@safesupply.com
Telephone: (416) 566-3872
Website: www.safesupply.com
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events.
The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Company's performance, business objectives and milestones and the anticipated timing thereof, and costs in connection with; the execution or achievement of such objectives and milestones; statements with respect to the growing market for narcotic testing and harm reduction solutions; statements with respect to the market for narcotic testing and harm reduction solutions experiencing rapid growth on a global scale; statements with respect to the success of the multi-year distribution agreement between Safety Strips and Greenlane; the success of Safety Strips' products; the Company's ability to complete the acquisition of Safety Strips; the integration of the Safety Strips products into the Company's portfolio; and statements with respect to the expansion of the Company's market presence due to continued growth, strategic acquisitions, and innovative partnerships.
Forward-looking information in this press release are based on certain assumptions and expected future events, namely: the Company's ability to maintain or exceed its current performance, and carry out its business objectives and milestones and under the anticipated timing and costs in connection with; the execution or achievement of such objectives and milestones; the Company's ability to capitalize on the potential benefits resulting from the potential distribution expansion in the North American market; the Company and Safety Strips' respective abilities to maintain its stated licenses and obtain all necessary additional licenses and regulatory approval required for it to carry out its plans as described; statements with respect to the growing market for narcotic testing and harm reduction solutions; statements with respect to the market for narcotic testing and harm reduction solutions experiencing rapid growth on a global scale; the ability for the Company to be a leader in the medical testing space; statements with respect to Safety Strips' ability to generate revenue from the sale of its products; the ability of the Company and Safety Strips to successfully integrate their businesses; and that there will be continued growth, strategic acquisitions, and innovative partnerships that would expand the Company's market presence.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Company's inability to maintain or exceed its current performance, and carry out its business objectives and milestones and under the anticipated timing and costs in connection with, the execution or achievement of such objectives and milestones; the Company's inability to capitalize on the potential benefits resulting from the potential distribution expansion in the North American market; either the Company's or Safety Strips' inability to maintain its stated licenses and obtain all necessary additional licenses and regulatory approval required for the Company or Safety Strips to carry out its plans as described; the Company's inability to significantly enhance its portfolio after any strategic acquisitions it may complete, including the proposed acquisition of Safety Strips; statements with respect to the growing market for narcotic testing and harm reduction solutions; statements with respect to the market for narcotic testing and harm reduction solutions experiencing rapid growth on a global scale; the inability of the Company and Safety Strips to successfully integrate their businesses; the ability for the Company to be a leader in the medical testing space due to the proposed acquisition of Safety Strips; and that there will be continued growth, strategic acquisitions, and innovative partnerships that would expand the Company's market presence.
Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/229445
FAQ
What is the new distribution agreement announced by Safe Supply Streaming (SSPLF)?
What products does Safety Strips Tech Corp offer under SSPLF?
How do Safety Strips' test products work?
